Consolidated Statements of Shareholders' Equity/Deficit - USD ($) |
Preferred Stock |
Common Stock |
Additional Paid-in Capital |
Retained Earnings |
Accumulated Other Comprehensive Income |
Total |
Noncontrolling Interest |
Total |
---|---|---|---|---|---|---|---|---|
Equity Balance, Starting at Dec. 31, 2017 | $ 0 | $ 2,281 | $ 12,560,619 | $ (6,063,977) | $ 34,822 | $ 6,533,745 | $ (187,132) | $ 6,346,613 |
Shares Outstanding, Starting at Dec. 31, 2017 | 0 | 22,814,283 | ||||||
Stock Issued During Period, Value, Conversion of Convertible Securities, Net of Adjustments | $ 0 | $ 45 | 629,160 | 0 | 0 | 629,205 | 0 | 629,205 |
Stock Issued During Period, Shares, Conversion of Convertible Securities | 0 | 442,597 | ||||||
Non-controlling distribution | $ 0 | $ 0 | 0 | 0 | 0 | 0 | (3,534) | (3,534) |
Net Income (Loss) | $ 0 | $ 0 | 0 | (409,161) | 0 | (409,161) | (11,118) | (420,279) |
Shares Outstanding, Ending at Dec. 31, 2018 | 11 | 23,139,837 | ||||||
Equity Balance, Ending at Dec. 31, 2018 | $ 0 | $ 2,314 | 13,071,626 | (6,438,316) | 0 | 6,635,624 | (201,784) | 6,433,840 |
Issuance of Series Q preferred stock | $ 0 | $ 0 | 109,985 | 0 | 0 | 109,985 | 0 | 109,985 |
Issuance of Series Q preferred stock, shares | 11 | 0 | ||||||
Shares canceled, Value | $ 0 | $ (12) | (228,138) | 0 | 0 | (228,150) | 0 | (228,150) |
Shares canceled, Shares | 0 | (117,043) | ||||||
Reclassification of unrealized gains on investments in equity securities | $ 0 | $ 0 | 0 | 34,822 | (34,822) | 0 | 0 | 0 |
Rescind sale of common stock to G Farma, Value | $ 0 | $ (29) | 29 | 0 | 0 | 0 | 0 | 0 |
Rescind sale of common stock to G Farma, Shares | 0 | (288,890) | ||||||
Non-controlling distribution | $ 0 | $ 0 | 0 | 0 | 0 | 0 | (2,524) | (2,524) |
Net Income (Loss) | $ 0 | $ 0 | 0 | (3,436,890) | 0 | (3,436,890) | 18,258 | (3,418,632) |
Shares Outstanding, Ending at Dec. 31, 2019 | 11 | 22,850,947 | ||||||
Equity Balance, Ending at Dec. 31, 2019 | $ 0 | $ 2,285 | $ 13,071,655 | $ (9,875,206) | $ 0 | $ 3,198,734 | $ (186,050) | $ 3,012,684 |
X | ||||||||||
- Definition Represents the Rescind sale of common stock to G Farma Shares (number of shares), during the indicated time period. No definition available.
|
X | ||||||||||
- Definition Represents the monetary amount of Rescind sale of common stock to G Farma Value, during the indicated time period. No definition available.
|
X | ||||||||||
- Definition Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount of tax expense (benefit) for reclassification adjustment from accumulated other comprehensive income (loss) for unrealized gain (loss) of investment classified as available-for-sale transferred to equity method. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Number of shares issued which are neither cancelled nor held in the treasury. No definition available.
|
X | ||||||||||
- Definition Number of shares issued during the period as a result of the conversion of convertible securities. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Number of shares of stock issued attributable to transactions classified as other. No definition available.
|
X | ||||||||||
- Definition The net amount of stock issued during the period upon the conversion of convertible securities, net of adjustments (for example, to additional paid in capital) including the write-off of an equity component recognized to record the convertible debt instrument as two separate components - a debt component and an equity component. This item is meant to disclose the value of shares issued on conversion of convertible securities that were recorded as two separate (debt and equity) components. No definition available.
|
X | ||||||||||
- Definition Value of shares of stock issued attributable to transactions classified as other. No definition available.
|
X | ||||||||||
- Definition Number of shares that have been repurchased and retired during the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Equity impact of the value of stock that has been repurchased and retired during the period. The excess of the purchase price over par value can be charged against retained earnings (once the excess is fully allocated to additional paid in capital). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|